Related references
Note: Only part of the references are listed.The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia
Roel Polak et al.
BLOOD (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
MK-2206, a Novel Allosteric Inhibitor of Akt, Synergizes with Gefitinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis
Yan Cheng et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia
L. Willems et al.
LEUKEMIA (2012)
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications
C. Grimaldi et al.
LEUKEMIA (2012)
The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation
E. Rao et al.
LEUKEMIA (2012)
The crosstalk between autophagy and apoptosis: where does this lead?
Claire Gordy et al.
PROTEIN & CELL (2012)
Next-generation Akt inhibitors provide greater specificity: effects on glucose metabolism in adipocytes
Shixiong Tan et al.
BIOCHEMICAL JOURNAL (2011)
Novel Inhibitors of AKT: Assessment of a Different Approach Targeting the Pleckstrin Homology Domain
E. J. Meuillet
CURRENT MEDICINAL CHEMISTRY (2011)
mTOR signaling in disease
Eva Dazert et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Developments in Selective Small Molecule ATP-Competitive Inhibitors Targeting the Serine/Threonine Kinase Akt/PKB
P. Wang et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
Occurrence of identical NOTCH1 mutation in non-twinned sisters with T-cell acute lymphoblastic leukemia
M. B. Mansur et al.
LEUKEMIA (2011)
TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells
B. A. Cardoso et al.
LEUKEMIA (2011)
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia
C. Evangelisti et al.
LEUKEMIA (2011)
Microarray detection of multiple recurring submicroscopic chromosomal aberrations in pediatric T-cell acute lymphoblastic leukemia
L. Yu et al.
LEUKEMIA (2011)
Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells
M. Masiero et al.
LEUKEMIA (2011)
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway
A. M. Martelli et al.
LEUKEMIA (2011)
Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL
M. L. Sulis et al.
LEUKEMIA (2011)
Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells
A. Silva et al.
LEUKEMIA (2011)
Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice
Michael G. Kharas et al.
BLOOD (2010)
T-Lymphoblastic Lymphoma Cells Express High Levels of BCL2, S1P1, and ICAM1, Leading to a Blockade of Tumor Cell Intravasation
Hui Feng et al.
CANCER CELL (2010)
Negative regulation of autophagy
C. Liang
CELL DEATH AND DIFFERENTIATION (2010)
mTOR regulation of autophagy
Chang Hwa Jung et al.
FEBS LETTERS (2010)
MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
Hiroshi Hirai et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways
W-L Zhao
LEUKEMIA (2010)
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms
A. M. Martelli et al.
LEUKEMIA (2010)
Dual Inhibition of Class IA Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin as a New Therapeutic Option for T-Cell Acute Lymphoblastic Leukemia
Francesca Chiarini et al.
CANCER RESEARCH (2009)
Autophagy in aging, disease and death: the true identity of a cell death impostor
B. Levine et al.
CELL DEATH AND DIFFERENTIATION (2009)
Targeting the leukemic stem cell: the Holy Grail of leukemia therapy
N. Misaghian et al.
LEUKEMIA (2009)
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability
Ana Silva et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Acute lymphoblastic leukaemia
Ching-Hon Pui et al.
LANCET (2008)
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism
F. Chiarini et al.
LEUKEMIA (2008)
It's T-ALL about Notch
R. M. Demarest et al.
ONCOGENE (2008)
Drug discovery approaches targeting the PI3K/Akt pathway in cancer
C. Garcia-Echeverria et al.
ONCOGENE (2008)
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells
V. Papa et al.
LEUKEMIA (2008)
Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia
Charlotte V. Cox et al.
BLOOD (2007)
Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of the EGF receptor
S. E. Winograd-Katz et al.
ONCOGENE (2006)
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways
Maria Nyakern et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia
H Kantarjian et al.
CANCER (2004)
Share Paper
